GILEAD SCIENCES INC (GIS.DE) Fundamental Analysis & Valuation

FRA:GIS • US3755581036

126.06 EUR
-1.4 (-1.1%)
Last: Mar 12, 2026, 04:42 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This GIS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, GIS scores 7 out of 10 in our fundamental rating. GIS was compared to 83 industry peers in the Biotechnology industry. GIS gets an excellent profitability rating and is at the same time showing great financial health properties. GIS is not valued too expensively and it also shows a decent growth rate. This makes GIS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. GIS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year GIS was profitable.
  • GIS had a positive operating cash flow in the past year.
  • Each year in the past 5 years GIS has been profitable.
  • In the past 5 years GIS always reported a positive cash flow from operatings.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • The Return On Assets of GIS (14.42%) is better than 90.36% of its industry peers.
  • The Return On Equity of GIS (37.49%) is better than 93.98% of its industry peers.
  • GIS's Return On Invested Capital of 19.49% is amongst the best of the industry. GIS outperforms 97.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GIS is significantly above the industry average of 12.16%.
  • The 3 year average ROIC (17.55%) for GIS is below the current ROIC(19.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 28.90%, GIS belongs to the top of the industry, outperforming 86.75% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GIS has grown nicely.
  • Looking at the Operating Margin, with a value of 39.98%, GIS belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
  • GIS's Operating Margin has been stable in the last couple of years.
  • GIS has a better Gross Margin (78.83%) than 66.27% of its industry peers.
  • GIS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. GIS.DE Health Analysis

2.1 Basic Checks

  • GIS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for GIS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, GIS has less shares outstanding
  • Compared to 1 year ago, GIS has an improved debt to assets ratio.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.64 indicates that GIS is not in any danger for bankruptcy at the moment.
  • GIS's Altman-Z score of 4.64 is fine compared to the rest of the industry. GIS outperforms 73.49% of its industry peers.
  • GIS has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as GIS would need 2.64 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.64, GIS belongs to the best of the industry, outperforming 84.34% of the companies in the same industry.
  • A Debt/Equity ratio of 0.97 indicates that GIS is somewhat dependend on debt financing.
  • GIS has a Debt to Equity ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.64
ROIC/WACC2.31
WACC8.44%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that GIS should not have too much problems paying its short term obligations.
  • GIS has a Current ratio (1.55) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.40 indicates that GIS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.40, GIS is in line with its industry, outperforming 44.58% of the companies in the same industry.
  • GIS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. GIS.DE Growth Analysis

3.1 Past

  • GIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • Measured over the past 5 years, GIS shows a small growth in Earnings Per Share. The EPS has been growing by 2.83% on average per year.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • Measured over the past years, GIS shows a small growth in Revenue. The Revenue has been growing by 3.58% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • Based on estimates for the next years, GIS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
  • The Revenue is expected to grow by 5.49% on average over the next years.
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. GIS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.91, GIS is valued on the expensive side.
  • Based on the Price/Earnings ratio, GIS is valued cheaper than 83.13% of the companies in the same industry.
  • GIS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
  • The Price/Forward Earnings ratio is 16.52, which indicates a correct valuation of GIS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GIS indicates a rather cheap valuation: GIS is cheaper than 91.57% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of GIS to the average of the S&P500 Index (24.27), we can say GIS is valued slightly cheaper.
Industry RankSector Rank
PE 17.91
Fwd PE 16.52
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GIS is valued cheaply inside the industry as 81.93% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GIS indicates a rather cheap valuation: GIS is cheaper than 89.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.17
EV/EBITDA 13.59
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GIS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.12
PEG (5Y)6.34
EPS Next 2Y9.79%
EPS Next 3Y9.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. GIS.DE Dividend Analysis

5.1 Amount

  • GIS has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.66, GIS pays a better dividend. On top of this GIS pays more dividend than 92.77% of the companies listed in the same industry.
  • GIS's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years6
Div Non Decr Years6
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 47.04% of the earnings are spent on dividend by GIS. This is a bit on the high side, but may be sustainable.
  • The dividend of GIS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GIS.DE Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

FRA:GIS (3/12/2026, 4:42:48 PM)

126.06

-1.4 (-1.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners92.51%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap156.49B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.05
Price Target134.83 (6.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend2.78
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)12.23%
PT rev (3m)16.13%
EPS NQ rev (1m)-7.64%
EPS NQ rev (3m)-6.84%
EPS NY rev (1m)-0.9%
EPS NY rev (3m)-0.29%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-1.41%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 17.91
Fwd PE 16.52
P/S 6.16
P/FCF 19.17
P/OCF 18.09
P/B 7.98
P/tB N/A
EV/EBITDA 13.59
EPS(TTM)7.04
EY5.58%
EPS(NY)7.63
Fwd EY6.05%
FCF(TTM)6.58
FCFY5.22%
OCF(TTM)6.97
OCFY5.53%
SpS20.48
BVpS15.79
TBVpS-1.8
PEG (NY)2.12
PEG (5Y)6.34
Graham Number50.01
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.64
F-Score8
WACC8.44%
ROIC/WACC2.31
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y10.85%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GIS.DE FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 7 / 10 to GIS.DE.


What is the valuation status of GILEAD SCIENCES INC (GIS.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GIS.DE) stock?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 9 / 10.


What is the financial health of GILEAD SCIENCES INC (GIS.DE) stock?

The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 8 / 10.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 8.46% in the next year.